نتایج جستجو برای: national immunisation programme nip
تعداد نتایج: 447470 فیلتر نتایج به سال:
The decision to introduce human papillomavirus (HPV) vaccination into the national immunisation programme in Spain was made in October 2007, recommending vaccination of girls aged between 11 and 14 years with three doses of HPV vaccine. All 19 regions of the country (17 Autonomous Communities and two Autonomous Cities) introduced HPV vaccination gradually into their immunisation programmes betw...
During the past two decades, immunisation has saved millions of lives and prevented countless illnesses and disabilities in South Africa(SA). However, vaccine-preventable diseases are still a threat. A vaccine-preventable disease that might lead to a 1- or 2-week illness in anadult, could prove deadly for infants, children or elderly people. Vaccination protects oneself and one's family. For ex...
Achieving high and equitable childhood immunisation coverage in Africa will not only protect children from disability and premature death, it will also boost productivity, reduce poverty and support the economic growth of the continent. Thus, Africa needs innovative and sustainable vaccine advocacy initiatives. One such initiative is the African Vaccine-Preventable Diseases Network, formed in 2...
Childhood immunisation has been credited with being responsible for reducing childhood morbidity and mortality over the past 40-50 years. It was the first item on the list of the Centers for Disease Control (CDC) for the ‘Ten great public health achievements’ of the 20th century. The viral diseases smallpox and poliomyelitis were eradicated in the United States of America as a result of vaccina...
BACKGROUND The Department of Health launched a national human papillomavirus immunisation programme for girls aged 12-13 years in September 2008. AIM To assess the feasibility and acceptability of implementing a school-based programme. METHOD HPV vaccination was offered over one academic year by two PCTs in 36 schools to 12-13-year-old girls, using different implementation plans. RESULTS ...
A National Vaccine Safety Workshop was held at the University of Sydney on 17 November 2005. The workshop was sponsored by the National Centre for Immunisation Research and Surveillance (NCIRS), the Australian Government Department of Health and Ageing (DoHA) and the National Immunisation Committee (NIC). It was attended by 40 invited representatives of federal, state and territory health depar...
BACKGROUND In Australia an adverse event following immunisation (AEFI), with the exception of anaphylaxis and encephalopathy, is no longer considered an absolute contraindication to continuing vaccination with the suspect vaccine. Despite these recommendations there is a paucity of information on the re-vaccination of such children. AIMS To describe the re-vaccination of a large number of chi...
نمودار تعداد نتایج جستجو در هر سال
با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید